Browne Jacobson advises Bio-Logic on Uniscan acquisition

April 30, 2012 - PRLog -- Bio-Logic SAS the French based scientific instrument manufacturer has reached agreement with the shareholders of Uniscan Instruments Limited (Buxton, UK) to acquire the British specialist manufacturer of electrochemistry instrumentation.

Uniscan Instruments will become a wholly owned subsidiary of the French Group, with the existing management team remaining in place.

Established in 1983 Bio-Logic SAS designs and manufactures research laboratory instruments for rapid kinetics and spectroscopy, electrochemistry and fuel cell, physiology and neuroscience, and photosynthesis applications. Its global distribution network spans  over twelve countries including Australia, Canada, China, France, Germany, India, Israel, Korea, Malaysia, Singapore, Spain, the United States, and the United Kingdom.

Formed in 1989, Uniscan Instruments has grown rapidly into a world leader for designing and developing precision measurement instruments based around electrochemical and optical technology.

Bio-Logic SAS was advised by Browne Jacobson Corporate Partner Richard Cox, assisted by Christina Swales. Debra Martin at law firm Geldards acted for the sellers.

Francois Goy, President of Bio-logic, commented: “The synergy of the businesses and the novel Uniscan technology adds another dimension to the Bio-logic portfolio of products for electrochemistry – equally it offers Uniscan the ability to gain a full market presence through the extensive Bio-logic network and we both look forward to an exciting period of growth.”

Richard Cox, Corporate Partner at Browne Jacobson, believes the deal reflects the increasing number of overseas investors and trade buyers who are currently targeting the UK market.

Recent inward investment deals Browne Jacobson has acted on include advising the French acoustic speaker manufacturer Focal on its merger with Naim Audio, Dutch based Macintosh Retail Group on its acquisition of Jones the Bootmaker and French school and office stationery manufacturer and supplier Maped’s acquisition of West Midlands based Helix.

“This deal is an important component in Bio-Logic’s expansion plans both in the UK and overseas. It will further strengthen our client’s position as well as safeguarding UK jobs.

“Companies who have carved out positions in attractive niche markets are particularly attractive to buyers. Overseas investors are also clearly confident in the long term prospects for the UK economy. Britain’s stable corporate governance structures and transparent and robust regulatory frameworks is a further crucial factor in this growing trend,” he added.